Celerion

47 articles about Celerion

• Celerion Appoints Dr. Robert Lester As Chief Cardiologist, Global Medical Director Of Cardiac Safety Services

  6/16/2014

• Celerion Selected By The Foundation For The National Institutes of Health (FNIH) Biomarkers Consortium For The Beta Cell Project

  6/11/2014

• Celerion Establishes Business Presence In Singapore And Appoints Dr. Chew Lan Chong As Executive Director, Medical Research

  6/4/2014

• Celerion And Korean Drug Development Fund Form Collaboration To Strengthen Early Phase Clinical Research In South Korea

  5/28/2014

• Celerion Opens Operations In South Korea At Seoul National University Hospital Clinical Trial Center

  3/4/2014

• Celerion Celebrates 80 Years Of Conducting Business At Global Headquarters In Lincoln, Nebraska

  12/17/2013

• Celerion Appoints John Horkulak As Executive Director, Eurasian Site Operations

  12/5/2013

• Celerion Expands Belfast Facility With Containment Room to Enable Live Biologics and Vaccine Studies

  6/5/2013

• Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine

  5/21/2013

• Celerion Builds on Respiratory Capabilities With the Addition of an On-Site Bronchoscopy Suite

  1/9/2013

• Celerion is the First CRO Headquartered in the USA to Receive Full Accreditation From AAHRPP

  9/17/2012

• Celerion Announces Expanded State-of-the-Art ADME Suite in Its Lincoln, Nebraska USA Facility

  5/17/2012

• Celerion and Ricerca Biosciences Announce “The Biosimilars Alliance” to Offer Clients a More Effective Development Path for Biosimilars

  2/29/2012

• Celerion Release: Verified Clinical Trials System Implemented at Leading Global Contract Research Organization to Improve Participant Safety and Data Integrity

  2/6/2012

• Celerion Highlights New Drug Discovery Research Solutions at the Society for Laboratory Automation and Screening (SLAS) 2012 Conference

  2/6/2012

• Celerion First Early Stage Contract Research Organization to Adopt a Participant Verification System to Improve Participant Safety and Data Quality

  2/2/2012

• Celerion Scientist Proud Recipient of Scientific and Technological Achievement Award (STAA) from EPA

  1/11/2012

• Celerion Receives License Enabling Investigational Medicinal Products (IMPs) to Be Imported Directly to Their GMP-Licensed Facility

  9/7/2011

• Celerion Appoints Dr. Raymond Farmen as Vice President of Global Bioanalytical Services

  6/29/2011

• Celerion Achieves Major Milestone of Successfully Analyzing Over 25,000 Platelet Aggregation Samples

  6/21/2011